-
Daniel I. FeigUniv. of AlabamaUSA
-
Dr. Feig completed his undergraduate degree in Molecular Biology at Princeton University, received his MD and PhD (Biochemistry) from the University of Washington and a Master’s Degree in Biostatistics and Clinical Investigation at Baylor College of Medicine. He trained in Pediatrics at Children’s of Seattle and Pediatric Nephrology at Boston Children’s Hospital. He spent 10 years on faculty at Texas Children’s Hospital where he founded the Multidisciplinary Program in Pediatric Hypertension. In 2011, Dr. Feig joined the faculty of UAB and Children’s of Alabama as Director of the Division of Nephrology.
Dr. Feig’s research focuses on the physiology of early onset essential hypertension. His studies have focused on the role of uric acid in the development hypertension and renal disease, cardiovascular risk of sweetener consumption and the diagnosis and management of pheochromocytomas in children.
Current National/International Service:
• American Board of Pediatrics, Nephrology Sub Board
• American Heart Association, Expert Panel on Cardiovascular Risk of Dietary Sweeteners
• American Academy of Pediatrics, Society of Nephrology Executive Board
• International Pediatric Hypertension Association: Education Chair
• Pediatric Academic Societies: National Program Committee
• Pediatric Pandemic Preparedness Network, Telemedicine Lead
He has been married for 31 years. His spouse, Trina is a Software Engineer and Professional Pastry Chef. They have has three sons age 28, 23 and 20.
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| May 19 | 13:30-14:00 | Room Grand Ballroom 103 | [International Symposium 4] Urate-Lowering Benefits and Risks on Comorbidities | The role of hyperuricemia in the progression of chronic kidney disease |
